Where does Jubilant Draximage Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Jubilant Draximage Inc. ranks #14,712 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Jubilant Draximage Inc. hold?

Jubilant Draximage Inc. holds 20 US utility patents granted between 2021 and 2025, spanning 16 technology areas.

What is Jubilant Draximage Inc.'s Innovation Score?

Jubilant Draximage Inc. has an Innovation Score of 55.3 out of 100 (top 7% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Jubilant Draximage Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Jubilant Draximage Inc..

What does claim depth mean for Jubilant Draximage Inc.'s patents?

Jubilant Draximage Inc.'s patents average 17.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Jubilant Draximage Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Jubilant Draximage Inc.

Q: What technology areas does Jubilant Draximage Inc. focus on?

Jubilant Draximage Inc.'s top technology area is G21G (Conversion OF Chemical ELEMENTS; Radioactive Sources) with 9 patents. Grants appear in 16 CPC subclasses total.

USPTO PatentsView assignee record - 20 granted patents across 16 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G21G (Conversion OF Chemical ELEMENTS; Radioactive Sources).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Jubilant ranks #14,712 of 49,997 tracked US assignees by granted-patent volume, with 20 patents across 16 technology areas.

#14,712
of 49,997 US assignees by volume: Top 7%
by Innovation Score (55.3/100): 17.7
avg claims per patent

USPTO PatentsView assignee plate

Corpus R14712 · Foreign Corporation #14,712 · 20 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-SMALL 20 grants
MID-PACK #14,712/49,997
PHOTO-FINISH Janssen BioPharma
CPC-FOCUS G21G · 16 areas
INNOV-PAR 55.3/100
CLAIMS-RICH 17.7 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2021–2025 · 5y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Janssen BioPharma, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Jubilant Draximage · this assignee

55
3D Lighting… · lowest

7

What this shows Jubilant's Innovation Score is 55.3/100 (top 7% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Jubilant's grants concentrate

Jubilant Draximage Inc. is a focused PatentsView assignee: 16 CPC subclasses with 45% of grants classified under G21G (Conversion OF Chemical ELEMENTS; Radioactive Sources). Peak complete grant year is 2024 (6 grants) versus a trough of 2 in 2022. By volume, Jubilant sits between Jost-werke Deutschland GMBH and KHD Humboldt Wedag GmbH.

Jubilant's three-year grant acceleration

Jubilant Draximage Inc. shows 12 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Jost-werke Deutsc…

20
JST Power Equipme…

20
Janssen Biopharma

20
Johnson Controls…

20
Just Fur Love

20
Kajeet

20
Keba

20
KHD Humboldt Wedag

20
Jubilant Draximage ◀

20

What this shows Jubilant holds 20 patents at rank #14,709, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Jubilant

By rank, the assignees closest to #14,709 in granted patent volume.

Leaders in G21G (Conversion OF Chemical Elements)

Other assignees with the most granted patents in Jubilant's primary technology class.

Jubilant's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

55 Top 7% higher than 93% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table

Jubilant Draximage Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2021	4	20.0%
2022	2	10.0%
2023	4	20.0%
2024	6	30.0%
2025partial year	4	20.0%

Which technologies does Jubilant Draximage Inc. patent most?

G21G - Conversion OF Chemical ELEMENTS; Radioactive Sources 9

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 7

G21F - Protection Against X-radiation, Gamma Radiation, Corpuscular Radiation OR Particle BOMBARDMENT; Treating Radioactively Contaminated MATERIAL; Decontamination Arrangements Therefor 6

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 4

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 4

A61B - DIAGNOSIS; SURGERY; Identification 2

F04B - Positive-displacement Machines FOR LIQUIDS; Pumps 2

G05B - Control OR Regulating Systems IN GENERAL; Functional Elements OF Such SYSTEMS; Monitoring OR Testing Arrangements FOR Such Systems OR Elements 2

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 2

B01D - Separation 2

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 1

G06V - Image OR Video Recognition OR Understanding 1

G06T - Image Data Processing OR Generation, IN General 1

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 1

B65B - Machines, Apparatus OR Devices FOR, OR Methods OF, Packaging Articles OR MATERIALS; Unpacking 1

Top 15 of 16 technology areas

Where it ranks

Overall rank by patents

#14,712

of 49,997 tracked assignees

Innovation Score

55.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Jubilant Draximage Inc.'s patent record in context - here's where to go next.

Jubilant Draximage Inc.'s lead technology class is G21G (Conversion OF Chemical ELEMENTS; Radioactive Sources), 45% of its portfolio - see every assignee active in that class. Explore G21G
Ranked #14,712 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Jubilant Draximage Inc. against Jost-werke Deutschland GMBH, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 55.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.